For the Inventor, By the Inventor

Enter inventor name

Wayland, MA, United States of America

Changgeng Qian

USPTO Granted Patents = 51 (Patent Applications = 11)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 10)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 265(Granted Patents)

Forward Citations (Not Self Cited) = 202(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

4. 2 out of 3,222

Genentech, Inc.

Leukosite, Inc.

Pharmaengine, Inc.

8. 1 out of 850

Millennium Pharmaceuticals Limited

where one patent can have more than one assignee

Years Active: 1997-2023

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Phosphoinositide 3-Kinase Inhibitors

HSP90 Inhibitors

Zinc Binding Moiety

Checkpoint Kinase 1 Inhibitors

Tyrosine Kinase Inhibitors

Quinazoline Based EGFR Inhibitors

CDK Inhibitors

Fused Amino Pyridine

Hedgehog Antagonists

Substituted 2-Indolinone

Cardiovascular Disorders

Cholinergic Receptor Agonists

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11654136 - Phosphoinositide 3-kinase inhibitor with a zinc binding moiety (2023-05-23),

2. 11597732 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety (2023-03-07),

3. 11560377 - Fused amino pyridine as HSP90 inhibitors (2023-01-24),

4. 11261195 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety (2022-03-01),

5. 11135205 - Phosphoinositide 3-kinase inhibitor with a zinc binding moiety (2021-10-05),

6. 11116767 - 3,5-disubstituted pyrazoles useful as checkpoint kinase 1 (Chk1) inhibitors, and their preparations and applications (2021-09-14),

7. 10894795 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety (2021-01-19),

8. 10844056 - Fused amino pyridine as HSP90 inhibitors (2020-11-24),

9. 10676482 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety (2020-06-09),

10. 10543197 - Phosphoinositide 3-kinase inhibitor with a zinc binding moiety (2020-01-28),

11. 10428068 - Fused amino pyridine as HSP90 inhibitors (2019-10-01),

12. 10214514 - Hedgehog antagonists having zinc binding moieties (2019-02-26),

13. 10035797 - Fused amino pyridine as HSP90 inhibitors (2018-07-31),

14. 9725461 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety (2017-08-08),

15. 9708299 - Hedgehog antagonists having zinc binding moieties (2017-07-18),

Title: The Innovative Journey of Changgeng Qian

Introduction: Changgeng Qian, a visionary inventor based in Wayland, MA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Changgeng Qian holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Changgeng Qian has led numerous successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Changgeng Qian has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and create impactful solutions for complex challenges.

Conclusion: Changgeng Qian's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…